Tonix Pharmaceuticals Holding Corp (TNXP)
0.1835
+0.01
(+7.25%)
USD |
NASDAQ |
May 03, 16:00
0.1723
-0.01
(-6.10%)
Pre-Market: 20:00
Tonix Pharmaceuticals Cash and Short Term Investments (Quarterly): 24.95M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 24.95M |
| September 30, 2023 | 6.914M |
| June 30, 2023 | 25.62M |
| March 31, 2023 | 71.98M |
| December 31, 2022 | 120.23M |
| September 30, 2022 | 139.98M |
| June 30, 2022 | 145.48M |
| March 31, 2022 | 140.44M |
| December 31, 2021 | 178.66M |
| September 30, 2021 | 182.97M |
| June 30, 2021 | 165.72M |
| March 31, 2021 | 164.21M |
| December 31, 2020 | 77.07M |
| September 30, 2020 | 55.66M |
| June 30, 2020 | 55.02M |
| March 31, 2020 | 30.66M |
| December 31, 2019 | 11.25M |
| September 30, 2019 | 10.02M |
| June 30, 2019 | 12.15M |
| March 31, 2019 | 16.45M |
| December 31, 2018 | 25.03M |
| September 30, 2018 | 14.67M |
| June 30, 2018 | 16.68M |
| March 31, 2018 | 19.25M |
| December 31, 2017 | 25.50M |
| Date | Value |
|---|---|
| September 30, 2017 | 29.31M |
| June 30, 2017 | 34.36M |
| March 31, 2017 | 22.42M |
| December 31, 2016 | 26.12M |
| September 30, 2016 | 26.74M |
| June 30, 2016 | 31.25M |
| March 31, 2016 | 27.49M |
| December 31, 2015 | 43.02M |
| September 30, 2015 | 55.05M |
| June 30, 2015 | 48.74M |
| March 31, 2015 | 58.18M |
| December 31, 2014 | 38.18M |
| September 30, 2014 | 46.23M |
| June 30, 2014 | 43.87M |
| March 31, 2014 | 49.55M |
| December 31, 2013 | 8.202M |
| September 30, 2013 | 7.420M |
| June 30, 2013 | 0.068M |
| March 31, 2013 | 0.4237M |
| December 31, 2012 | 1.785M |
| September 30, 2012 | 0.0357M |
| June 30, 2012 | 1.338M |
| March 31, 2012 | 2.501M |
| December 31, 2011 | 0.0411M |
| September 30, 2011 | 0.0002M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
6.914M
Minimum
Sep 2023
182.97M
Maximum
Sep 2021
85.21M
Average
71.98M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| PetVivo Holdings Inc | 0.0801M |
| Acurx Pharmaceuticals Inc | 7.474M |
| Kezar Life Sciences Inc | 201.37M |
| Allakos Inc | 170.79M |
| RAPT Therapeutics Inc | 158.86M |